BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 16077921)

  • 1. Extraction and processing of high quality RNA from impalpable and macroscopically invisible prostate cancer for microarray gene expression analysis.
    Schlomm T; Luebke AM; Sültmann H; Hellwinkel OJ; Sauer U; Poustka A; David KA; Chun FK; Haese A; Graefen M; Erbersdobler A; Huland H
    Int J Oncol; 2005 Sep; 27(3):713-20. PubMed ID: 16077921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. cDNA microarray analysis with amplified RNA after isolation of intact cellular RNA from neoplastic and non-neoplastic prostate tissue separated by laser microdissections.
    Thelen P; Burfeind P; Grzmil M; Voigt S; Ringert RH; Hemmerlein B
    Int J Oncol; 2004 May; 24(5):1085-92. PubMed ID: 15067329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulated expression of the MAT-8 gene in prostate cancer and its siRNA-mediated inhibition of expression induces a decrease in proliferation of human prostate carcinoma cells.
    Grzmil M; Voigt S; Thelen P; Hemmerlein B; Helmke K; Burfeind P
    Int J Oncol; 2004 Jan; 24(1):97-105. PubMed ID: 14654946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microarray-based expression profiling in prostate tumors.
    Elek J; Park KH; Narayanan R
    In Vivo; 2000; 14(1):173-82. PubMed ID: 10757075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a method for profiling gene expression in cells recovered from intact human prostate tissue using RNA linear amplification.
    Ding Y; Xu L; Chen S; Jovanovic BD; Helenowski IB; Kelly DL; Catalona WJ; Yang XJ; Pins M; Ananthanarayanan V; Bergan RC
    Prostate Cancer Prostatic Dis; 2006; 9(4):379-91. PubMed ID: 16786039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy.
    Haram KM; Peltier HJ; Lu B; Bhasin M; Otu HH; Choy B; Regan M; Libermann TA; Latham GJ; Sanda MG; Arredouani MS
    Prostate; 2008 Oct; 68(14):1517-30. PubMed ID: 18668517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiling reveals overexpression of TSPAN13 in prostate cancer.
    Arencibia JM; Martín S; Pérez-Rodríguez FJ; Bonnin A
    Int J Oncol; 2009 Feb; 34(2):457-63. PubMed ID: 19148481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptome analyses of benign and malignant prostate epithelial cells in formalin-fixed paraffin-embedded whole-mounted radical prostatectomy specimens.
    Furusato B; Shaheduzzaman S; Petrovics G; Dobi A; Seifert M; Ravindranath L; Nau ME; Werner T; Vahey M; McLeod DG; Srivastava S; Sesterhenn IA
    Prostate Cancer Prostatic Dis; 2008; 11(2):194-7. PubMed ID: 17768422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of gene expression profile in colon cancer using the Cancer Genome Anatomy Project and RNA interference.
    Huang ZG; Ran ZH; Lu W; Xiao SD
    Chin J Dig Dis; 2006; 7(2):97-102. PubMed ID: 16643337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression in the LNCaP human prostate cancer progression model: progression associated expression in vitro corresponds to expression changes associated with prostate cancer progression in vivo.
    Chen Q; Watson JT; Marengo SR; Decker KS; Coleman I; Nelson PS; Sikes RA
    Cancer Lett; 2006 Dec; 244(2):274-88. PubMed ID: 16500022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimized procedures for microarray analysis of histological specimens processed by laser capture microdissection.
    Upson JJ; Stoyanova R; Cooper HS; Patriotis C; Ross EA; Boman B; Clapper ML; Knudson AG; Bellacosa A
    J Cell Physiol; 2004 Dec; 201(3):366-73. PubMed ID: 15389559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular features of hormone-refractory prostate cancer cells by genome-wide gene expression profiles.
    Tamura K; Furihata M; Tsunoda T; Ashida S; Takata R; Obara W; Yoshioka H; Daigo Y; Nasu Y; Kumon H; Konaka H; Namiki M; Tozawa K; Kohri K; Tanji N; Yokoyama M; Shimazui T; Akaza H; Mizutani Y; Miki T; Fujioka T; Shuin T; Nakamura Y; Nakagawa H
    Cancer Res; 2007 Jun; 67(11):5117-25. PubMed ID: 17545589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative RT-PCR analysis of estrogen receptor gene expression in laser microdissected prostate cancer tissue.
    Walton TJ; Li G; McCulloch TA; Seth R; Powe DG; Bishop MC; Rees RC
    Prostate; 2009 Jun; 69(8):810-9. PubMed ID: 19189301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of gene expression during nasopharyngeal carcinogenesis revealed by oligonucleotide microarray after microdissection of tumor tissue and normal epithelia from nasopharynx.
    Liu ZQ; Tian YQ; Hu YF; Li XL; Ma FR; Li GY
    Chin Med J (Engl); 2009 Feb; 122(4):437-43. PubMed ID: 19302751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Establishment of cDNA microarray technology and analysis of gene expression profiles in human esophageal cancer cell line ECa109].
    Li P; Ling Z; Zhao J; Yang H; Huang Y; Zhao M; Dong Z
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Apr; 25(2):413-8. PubMed ID: 18610633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential gene expression profiles of radioresistant pancreatic cancer cell lines established by fractionated irradiation.
    Ogawa K; Utsunomiya T; Mimori K; Tanaka F; Haraguchi N; Inoue H; Murayama S; Mori M
    Int J Oncol; 2006 Mar; 28(3):705-13. PubMed ID: 16465376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gene expression profiling in prostatic cancer].
    Ernst T; Hergenhahn M; Kenzelmann M; Cohen CD; Ikinger U; Kretzler M; Hollstein M; Gröne HJ
    Verh Dtsch Ges Pathol; 2002; 86():165-75. PubMed ID: 12647366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate-specific antigen mRNA and protein levels in laser microdissected cells of human prostate measured by real-time reverse transcriptase-quantitative polymerase chain reaction and immuno-quantitative polymerase chain reaction.
    Pinzani P; Lind K; Malentacchi F; Nesi G; Salvianti F; Villari D; Kubista M; Pazzagli M; Orlando C
    Hum Pathol; 2008 Oct; 39(10):1474-82. PubMed ID: 18619642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of differentially expressed genes in human prostate cancer using subtraction and microarray.
    Xu J; Stolk JA; Zhang X; Silva SJ; Houghton RL; Matsumura M; Vedvick TS; Leslie KB; Badaro R; Reed SG
    Cancer Res; 2000 Mar; 60(6):1677-82. PubMed ID: 10749139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Change of the cell cycle after flutamide treatment in prostate cancer cells and its molecular mechanism.
    Wang Y; Shao C; Shi CH; Zhang L; Yue HH; Wang PF; Yang B; Zhang YT; Liu F; Qin WJ; Wang H; Shao GX
    Asian J Androl; 2005 Dec; 7(4):375-80. PubMed ID: 16281084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.